Skip to content

Zymeworks ZYME Number of reportable segments

Number of reportable segments at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
0.3
Charles River Laboratories logo
Charles River LaboratoriesCRL
30.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
10.0%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:NumberOfReportableSegments.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's number of reportable segments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's number of reportable segments?
Zymeworks (ZYME) reported number of reportable segments of 1 in Q1 2026.
What does number of reportable segments mean?
The total count of distinct business units or segments for which the company reports separate financial information. This metric indicates the organizational complexity and the diversity of the company's operational focus.